Deal facts
- Buyer
- PURE HEALTH HOLDING
- Target
- HELLENIC HEALTHCARE
- Deal value
- Not disclosed
- Announced
- 23 February 2025
- Status
- In review
- Sector
- Healthcare
- Country
- Not stated
- Consideration
- Not stated
Sources
PURE HEALTH HOLDING has agreed to acquire HELLENIC HEALTHCARE in a transaction announced on 23 February 2025. The deal involves a company operating within the NaceV2Sector_R_86.1 classification, which relates to medical activities. No financial consideration or deal value has been disclosed to the public at this time. The specific structure of the acquisition, whether it constitutes a management buyout, buy-in, or merger, remains unconfirmed in the available records.
The transaction is currently in the review phase with the last recorded status indicating that regulatory or internal approvals are pending. Completion has not yet been finalised, and no specific date for closing has been reported. Further details regarding the target's location or the exact nature of the consideration are not available in the current dataset. The parties involved are expected to proceed once all necessary conditions for the deal are satisfied. The transaction is subject to regulatory approval.
Weekly digest
Join Exit Mode Insider
Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.
Join Exit Mode Insider, £12/moDeal timeline
1 update- CMA invitation to comment
PURE HEALTH HOLDING to acquire HELLENIC HEALTHCARE
PURE HEALTH HOLDING to acquire HELLENIC HEALTHCARE
EU DG COMP
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
KOHLBERG / MONTAGU to acquire TELEFLEX OEM BUSINESS
KOHLBERG / MONTAGU has agreed to acquire the TELEFLEX OEM Business in a transaction announced on 22 March 2026. The deal involves a company operating within the NaceV2Se…
- Buyer
- KOHLBERG / MONTAGU
- Target
- TELEFLEX OEM BUSINESS
- Deal value
- Not disclosed
- Deal type
- unknown
SK CAPITAL to acquire SWIXX BIOPHARMA
SK CAPITAL has agreed to acquire SWIXX BIOPHARMA in a transaction announced on 8 March 2026. The deal involves the biopharmaceutical sector, specifically within the whol…
- Buyer
- SK CAPITAL
- Target
- SWIXX BIOPHARMA
- Deal value
- Not disclosed
- Deal type
- unknown
EQT to acquire Oxford Biomedica plc
EQT has agreed to acquire Oxford Biomedica plc, a UK-based CDMO and viral vector specialist, in a transaction announced on 25 February 2026. The specific financial terms…
- Buyer
- EQT
- Target
- Oxford Biomedica plc
- Deal value
- Not disclosed
- Deal type
- unknown
GTCR to acquire ZENTIVA
GTCR has agreed to acquire ZENTIVA in a transaction announced on 19 February 2026. The deal involves the pharmaceutical sector, classified under NaceV2Sector_C_21. No fi…
- Buyer
- GTCR
- Target
- ZENTIVA
- Deal value
- Not disclosed
- Deal type
- unknown
WARBURG PINCUS to acquire SEBIA
WARBURG PINCUS has agreed to acquire SEBIA in a transaction announced on 12 November 2025. The deal involves a company operating across multiple industrial sectors, incl…
- Buyer
- WARBURG PINCUS
- Target
- SEBIA
- Deal value
- Not disclosed
- Deal type
- unknown
Buyer history
PURE HEALTH HOLDING
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive
